Additionally, Zn deficiency may have implications for AD, as observed in human postmortem brain tissue from individuals with AD, which were characterized by a significant loss of ZnT3 expression in cortical regions compared to control subjects, as well as in transgenic mice, in which a low-Zn diet was associated with a substantial increase in plaque volume [164,166]. Here, SLC30A3 is linked to Alzheimer disease.